FOLH1 and pachyonychia congenita: In this study, we investigated the performance and associated toxicity of [177Lu]Lu-PSMA-617 and [225Ac]Ac-PSMA-617 in RM1-PGLS, a reliable immunocompetent PSMA-positive PC murine model that also accounts for antitumor immune response (Fendler et al. 2017).